Manganese oxide nanoparticles (MONPs) are capable of time-dependent magnetic resonance imaging contrast switching as well as releasing a surface-bound drug. MONPs give T2/T2* contrast, but dissolve and release T1-active Mn(2+) and L-3,4-dihydroxyphenylalanine. Complementary images are acquired with a single contrast agent, and applications toward Parkinson's disease are suggested.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/smll.201502545 | DOI Listing |
Publication Analysis
Top Keywords
manganese oxide
8
oxide nanoparticles
8
l-dopa-coated manganese
4
nanoparticles dual
4
dual mri
4
contrast
4
mri contrast
4
contrast agents
4
agents drug-delivery
4
drug-delivery vehicles
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!